Seckl Michael J, Gillmore Roopinder, Foskett Marianne, Sebire Neil J, Rees Helene, Newlands Edward S
Gestational Trophoblastic Disease Unit, Department of Medical Oncology, Charing Cross and Hammersmith Hospitals Campus, Imperial College London, Fulham Palace Road, London W6 8RF, UK.
Lancet. 2004;364(9435):705-7. doi: 10.1016/S0140-6736(04)16898-0.
After termination of pregnancy for non-medical reasons, the products of conception are often not routinely examined for gestational trophoblastic neoplasia. Between 1995 and 2001 we identified 15 women without and 36 women with a pathological diagnosis of gestational trophoblastic neoplasia at the time of their pregnancy termination. Women without a diagnosis were significantly more likely to have subsequent life-threatening complications of gestational trophoblastic neoplasia (four of 15 vs none of 36; p=0.003), and to require surgical intervention (15 of 15 vs one of 36; p<0.0001) and chemotherapy (nine of 15 vs two of 36; p<0.0001). All women should be screened for gestational trophoblastic neoplasia after termination of pregnancy.
非医学原因终止妊娠后,通常不会对妊娠产物进行常规的妊娠滋养细胞肿瘤检查。在1995年至2001年期间,我们确定了15名在终止妊娠时未被病理诊断为妊娠滋养细胞肿瘤的女性和36名被病理诊断为妊娠滋养细胞肿瘤的女性。未被诊断出的女性发生后续危及生命的妊娠滋养细胞肿瘤并发症的可能性显著更高(15例中有4例,而36例中无1例;p = 0.003),并且需要手术干预(15例中有15例,而36例中有1例;p<0.0001)和化疗(15例中有9例,而36例中有2例;p<0.0001)。所有女性在终止妊娠后都应接受妊娠滋养细胞肿瘤筛查。